Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients

BACKGROUND: Venous thromboembolism (VTE) can be encountered by 60% of hospitalized patients. Anticoagulants have been recommended to reduce the risk of VTE in patients with risk factors. However, no specific dosing recommendations for obese patients are provided in the current practice guidelines. T...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Thorac Med
Главные авторы: Al Otaib, Nouf, Bootah, Zohour, Al Ammari, Maha A., Aldebasi, Tariq M., Alkatheri, Abdulmalik M., Al Harbi, Shmeylan A., AbuRuz, Salah M., AlBekairy, Abdulkareem M.
Формат: Artigo
Язык:Inglês
Опубликовано: Medknow Publications & Media Pvt Ltd 2017
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5541968/
https://ncbi.nlm.nih.gov/pubmed/28808492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/atm.ATM_31_17
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы